The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials

@article{Rudick2002TheMS,
  title={The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials},
  author={R. Rudick and G. Cutter and S. Reingold},
  journal={Multiple Sclerosis},
  year={2002},
  volume={8},
  pages={359 - 365}
}
  • R. Rudick, G. Cutter, S. Reingold
  • Published 2002
  • Medicine
  • Multiple Sclerosis
  • With the advent and widespread use of partially effective disease modifying drug therapies for multiple sclerosis (MS), future clinical trials will undoubtedly test experimental interventions against standard therapy, or will test combinations of drugs against standard therapy. In either case, incremental progress in slowing disability progression in future MS clinical trials will require much larger sample sizes, more sensitive outcome measures, or a combination of the two. Because improved… CONTINUE READING
    181 Citations
    Possible clinical outcome measures for clinical trials in patients with multiple sclerosis
    • 106
    • PDF
    Functional clinical outcomes in multiple sclerosis: Current status and future prospects.
    • 17
    Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions
    • 19
    • PDF
    Walking impairment in patients with multiple sclerosis - a new therapeutic approach and clinical potential of dalfampridine extended release tablets.
    • 3
    • PDF

    References

    SHOWING 1-10 OF 24 REFERENCES
    Development of a multiple sclerosis functional composite as a clinical trial outcome measure.
    • 1,020
    • PDF
    Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
    • 155
    • PDF
    Clinical outcomes assessment in multiple sclerosis
    • 166
    MS Functional Composite
    • 92